Akso Health Group
5 hedge funds and large institutions have $285K invested in Akso Health Group in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
5% more capital invested
Capital invested by funds: $271K → $285K (+$13.7K)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$40.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$22.5K |
| 2 |
Renaissance Technologies
New York
|
-$20.1K |
AHG Hedge Fund Activity: Q4 2025 in Review
5 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q4 2025, worth a combined $285K — up 5.1% from $271K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new AHG positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Northern Trust, opening a new position worth an estimated $40.3K. The largest seller was UBS Group, exiting entirely with an estimated $22.5K sold.
- 5 institutional investors held Akso Health Group (AHG) as of Q4 2025, up from 4 in Q3 2025.
- Funds reported $285K of Akso Health Group stock for Q4 2025, up 5.1% quarter-over-quarter.
- 2 funds opened new Akso Health Group positions in Q4 2025 and 1 closed out, a net change of +1 holder.
- The largest Akso Health Group buyer in Q4 2025 was Northern Trust, an estimated $40.3K added.
- The largest Akso Health Group seller in Q4 2025 was UBS Group, an estimated $22.5K sold.
Based on aggregated 13F filings for Q4 2025.